Inogen Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Good afternoon. I would like to welcome everybody to the second day of the KeyBanc Life Sciences and MedTech Investor Forum. My name is Matt Mishan; I'm our senior med tech analyst. And I'm pleased to be joined by Inogen, who is represented today by its CEO, Nabil Shabshab; and its CFO, Kristin Caltrider. (Conference Instructions)
Hey, Nabil, thank you very much for joining us. I'll let you introduce the rest of your team. Who is with you today?
Hey, Matt. Good to see you. So in addition to Kristin Caltrider, who's the CFO that joined us a few days ago, only this is her third day. I've got George Parr, who is our Chief Commercial Officer. I've got Stan Glezer, who is our Chief Technology Officer, and Mike Sergesketter is with us, with the role he served as the Interim CFO for the last 2.5 months.
Questions & Answers
Okay. Excellent. Let's just
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |